Document is current
Any future updates will be listed below
-
Authors
Fernández-Rodríguez, Paula https://orcid.org/0000-0002-8669-5389
Franco-Rosado, Pablo https://orcid.org/0000-0002-7433-069X
Diaz-Galvan, Patricia https://orcid.org/0000-0001-6155-5585
Muñoz-Delgado, Laura https://orcid.org/0000-0002-8818-1824
Luque-Ambrosiani, Antonio Cristobal https://orcid.org/0000-0003-0689-049X
Labrador-Espinosa, Miguel Ángel https://orcid.org/0000-0003-3576-1777
Silva-Rodríguez, Jesús https://orcid.org/0000-0002-5196-0103
Ojeda-Lepe, Elena https://orcid.org/0009-0002-0054-7869
Macías-García, Daniel https://orcid.org/0000-0002-4822-1529
Adarmes-Gómez, Astrid https://orcid.org/0000-0002-1337-9289
Jesús, Silvia https://orcid.org/0000-0002-1874-4628
Carrillo, Fátima
Lojo-Ramírez, Jose Antonio https://orcid.org/0000-0003-4945-8250
Solis, David García
Grothe, Michel J. https://orcid.org/0000-0003-2600-9022
Mir, Pablo https://orcid.org/0000-0003-1656-302X
-
Funding
Funding for this research was provided by:
Universidad de Sevilla
- License Information
-
More Information
Article History
Received: 27 January 2026
Accepted: 15 June 2026
First Online: 3 July 2026
Declarations
:
: DMG has received honoraria from AbbVie and Merz. AAG has received honoraria from AbbVie, Bial, Merz, Italfarmaco, Esteve and Zambon. SJ has received honoraria from AbbVie, Bial, Merz, UCB, Italfarmaco, Orion and Zambon. LMD has received honoraria from AbbVie, Merz and Zambon. Paula FR has received support from GE HealthCare. PM has also received support for attending meetings and/or travel or honorarium for lecturing from AbbVie, Abbott, Allergan, Bial, Merz, UCB, and Zambon. The remaining authors declare that they have no relevant financial or non-financial interests to disclose.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hospital Universitario Virgen del Rocío.
: Written informed consent was obtained from all alive participants during their clinical visits. For deceased patients, the ethics committees explicitly authorized the retrospective use of their imaging and clinical data without the need for additional consent.
